Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.
St Georgiev
V
V
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003049:Coccidiostats / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy* / Q000276:immunology; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D014122:Toxoplasma / Q000187:drug effects; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000276:immunology
D000900:Anti-Bacterial Agents; D003049:Coccidiostats